The studies with C-MET and other receptor tyrosine kinases indicate that caution must be taken when entering into the clinic and that sometimes, inhibition of shedding can lead to an exacerbation of a disease such as cancer, depending on the tumor microenvironment and the presence or absence of certain signaling molecules. Here, NTRK1 is linked to neoplasm.